163 related articles for article (PubMed ID: 23335200)
21. Brain imaging features of children with Hoyeraal-Hreidarsson syndrome.
Zhang MJ; Cao YX; Wu HY; Li HH
Brain Behav; 2021 May; 11(5):e02079. PubMed ID: 33734615
[TBL] [Abstract][Full Text] [Related]
22. Telomere shortening by mutations in the RTEL1 helicase cause severe form of dyskeratosis congenita, Hoyerall-Hreidarsson syndrome.
Lee JW
Clin Genet; 2013 Sep; 84(3):210. PubMed ID: 23621889
[No Abstract] [Full Text] [Related]
23. Full length RTEL1 is required for the elongation of the single-stranded telomeric overhang by telomerase.
Awad A; Glousker G; Lamm N; Tawil S; Hourvitz N; Smoom R; Revy P; Tzfati Y
Nucleic Acids Res; 2020 Jul; 48(13):7239-7251. PubMed ID: 32542379
[TBL] [Abstract][Full Text] [Related]
24. Compound heterozygous mutations in the helicase RTEL1 causing Hoyeraal-Hreidarsson syndrome with Blake`s pouch cyst: a case report.
He M; Lian G; Hu H; He H; Wang M
Turk J Pediatr; 2023; 65(5):845-852. PubMed ID: 37853975
[TBL] [Abstract][Full Text] [Related]
25. Mutations of the RTEL1 Helicase in a Hoyeraal-Hreidarsson Syndrome Patient Highlight the Importance of the ARCH Domain.
Jullien L; Kannengiesser C; Kermasson L; Cormier-Daire V; Leblanc T; Soulier J; Londono-Vallejo A; de Villartay JP; Callebaut I; Revy P
Hum Mutat; 2016 May; 37(5):469-72. PubMed ID: 26847928
[TBL] [Abstract][Full Text] [Related]
26. rRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity from yeast to human cells.
Jack K; Bellodi C; Landry DM; Niederer RO; Meskauskas A; Musalgaonkar S; Kopmar N; Krasnykh O; Dean AM; Thompson SR; Ruggero D; Dinman JD
Mol Cell; 2011 Nov; 44(4):660-6. PubMed ID: 22099312
[TBL] [Abstract][Full Text] [Related]
27. Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1.
Knight SW; Heiss NS; Vulliamy TJ; Aalfs CM; McMahon C; Richmond P; Jones A; Hennekam RC; Poustka A; Mason PJ; Dokal I
Br J Haematol; 1999 Nov; 107(2):335-9. PubMed ID: 10583221
[TBL] [Abstract][Full Text] [Related]
28. Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation.
Thumati NR; Zeng XL; Au HH; Jang CJ; Jan E; Wong JM
Hum Mutat; 2013 Dec; 34(12):1698-707. PubMed ID: 24115260
[TBL] [Abstract][Full Text] [Related]
29. From incomplete penetrance with normal telomere length to severe disease and telomere shortening in a family with monoallelic and biallelic PARN pathogenic variants.
Dodson LM; Baldan A; Nissbeck M; Gunja SMR; Bonnen PE; Aubert G; Birchansky S; Virtanen A; Bertuch AA
Hum Mutat; 2019 Dec; 40(12):2414-2429. PubMed ID: 31448843
[TBL] [Abstract][Full Text] [Related]
30. NHP2 deficiency impairs rRNA biogenesis and causes pulmonary fibrosis and Høyeraal-Hreidarsson syndrome.
Benyelles M; O'Donohue MF; Kermasson L; Lainey E; Borie R; Lagresle-Peyrou C; Nunes H; Cazelles C; Fourrage C; Ollivier E; Marcais A; Gamez AS; Morice-Picard F; Caillaud D; Pottier N; Ménard C; Ba I; Fernandes A; Crestani B; de Villartay JP; Gleizes PE; Callebaut I; Kannengiesser C; Revy P
Hum Mol Genet; 2020 Apr; 29(6):907-922. PubMed ID: 31985013
[TBL] [Abstract][Full Text] [Related]
31. Further delineation of the congenital form of X-linked dyskeratosis congenita (Hoyeraal-Hreidarsson syndrome).
Sznajer Y; Baumann C; David A; Journel H; Lacombe D; Perel Y; Blouin P; Segura JF; Cezard JP; Peuchmaur M; Vulliamy T; Dokal I; Verloes A
Eur J Pediatr; 2003 Dec; 162(12):863-7. PubMed ID: 14648217
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneous telomere defects in patients with severe forms of dyskeratosis congenita.
Touzot F; Gaillard L; Vasquez N; Le Guen T; Bertrand Y; Bourhis J; Leblanc T; Fischer A; Soulier J; de Villartay JP; Revy P
J Allergy Clin Immunol; 2012 Feb; 129(2):473-82, 482.e1-3. PubMed ID: 22078571
[TBL] [Abstract][Full Text] [Related]
33. The longest surviving child with Hoyeraal-Hreidarsson Syndrome.
Ozdemir MA; Karakukcu M; Kose M; Kumandas S; Gumus H
Haematologica; 2004 Sep; 89(9):ECR38. PubMed ID: 15377490
[TBL] [Abstract][Full Text] [Related]
34. Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome.
Marrone A; Walne A; Tamary H; Masunari Y; Kirwan M; Beswick R; Vulliamy T; Dokal I
Blood; 2007 Dec; 110(13):4198-205. PubMed ID: 17785587
[TBL] [Abstract][Full Text] [Related]
35. High resolution melting analysis for the identification of novel mutations in DKC1 and TERT genes in patients with dyskeratosis congenita.
Carrillo J; Martínez P; Solera J; Moratilla C; González A; Manguán-García C; Aymerich M; Canal L; Del Campo M; Dapena JL; Escoda L; García-Sagredo JM; Martín-Sala S; Rives S; Sevilla J; Sastre L; Perona R
Blood Cells Mol Dis; 2012 Oct 15-Dec 15; 49(3-4):140-6. PubMed ID: 22664374
[TBL] [Abstract][Full Text] [Related]
36. [RTEL1 (regulator of telomere elongation helicase 1), a DNA helicase essential for genome stability].
Le Guen T; Jullien L; Schertzer M; Lefebvre A; Kermasson L; de Villartay JP; Londoño-Vallejo A; Revy P
Med Sci (Paris); 2013 Dec; 29(12):1138-44. PubMed ID: 24356145
[TBL] [Abstract][Full Text] [Related]
37. Impaired telomere integrity and rRNA biogenesis in PARN-deficient patients and knock-out models.
Benyelles M; Episkopou H; O'Donohue MF; Kermasson L; Frange P; Poulain F; Burcu Belen F; Polat M; Bole-Feysot C; Langa-Vives F; Gleizes PE; de Villartay JP; Callebaut I; Decottignies A; Revy P
EMBO Mol Med; 2019 Jul; 11(7):e10201. PubMed ID: 31273937
[TBL] [Abstract][Full Text] [Related]
38. [Hoyeraal-Hreidarsson syndrome with combined immunodeficiency and enterocolitis caused by a DCK1 gene variant].
Yang CR; Wei Q; Jiang M; Zhang XB; Zhang ZX; Nong GM
Zhonghua Er Ke Za Zhi; 2022 Mar; 60(3):248-249. PubMed ID: 35240749
[TBL] [Abstract][Full Text] [Related]
39. Dyskeratosis congenita.
Marrone A; Mason PJ
Cell Mol Life Sci; 2003 Mar; 60(3):507-17. PubMed ID: 12737310
[TBL] [Abstract][Full Text] [Related]
40. Telomere-driven diseases and telomere-targeting therapies.
Martínez P; Blasco MA
J Cell Biol; 2017 Apr; 216(4):875-887. PubMed ID: 28254828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
